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Galectin-3 (Gal-3) has a role in multiple inflammatory pathways. Various, opposite roles
of Gal-3 in liver diseases have been described but there are no data about the role
of Gal-3 in development of hepatitis induced with cytomegalovirus infection. In this
study we aimed to clarify the role of Gal-3 in murine cytomegalovirus (MCMV)-induced
hepatitis by using Gal-3–deficient (Gal-3 KO) mice. Here we provide the evidence
that Gal-3 has the protective role in MCMV-induced hepatitis. Enhanced hepatitis
manifested by more inflammatory and necrotic foci and serum level of ALT, enhanced
apoptosis and necroptosis of hepatocytes and enhanced viral replication were detected
in MCMV-infected Gal-3 deficient mice. NK cells does not contribute to more severe
liver damage in MCMV-infected Gal-3 KO mice. Enhanced expression of TNF-α in the
hepatocytes of Gal-3 KO mice after MCMV infection, abrogated hepatocyte death, and
attenuated inflammation in the livers of Gal-3 KO mice after TNF-α blockade suggest
that TNF-α plays the role in enhanced disease in Gal-3 deficient animals. Treatment with
recombinant Gal-3 reduces inflammation and especially necrosis of hepatocytes in the
livers of MCMV-infected Gal-3 KO mice. Our data highlight the protective role of Gal-3
in MCMV-induced hepatitis by attenuation of TNF-α-mediated death of hepatocytes.
Keywords: galectin-3, hepatitis, murine cytomegalovirus infection, TNF-α, hepatocyte death
INTRODUCTION
Infection with human cytomegalovirus (HCMV) is typically asymptomatic in immunocompetent
individuals, but in individuals with immature or deficient immune system HCMV is a cause of
morbidity and mortality (Mocarski et al., 2007). In immunocompromised hosts, especially in
transplant recipients, HCMV induces severe hepatitis that elevates mortality (Bozza et al., 2007;
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Mocarski et al., 2013). A better understanding of HCMV-
induced liver damage could provide insights into potential
novel therapeutic strategies for immunocompromised patients
(Livingston-Rosanoff et al., 2012). Murine CMV (MCMV)
causes a chronic infection with initial hepatic inflammation
and damage and is the most widely used model to study the
pathogenesis of human CMV disease (Livingston-Rosanoff et al.,
2012; Brune, 2013). In C57BL/6 mice NK cells, recruited by
inflammatory monocytes, play a crucial role in the early control
of MCMV infection by both NK cell-mediated cytotoxicity and
the production of effector cytokines (Smith et al., 2002; Scalzo
and Yokoyama, 2008). Infection promotes liver inflammation
by enhancing IL-1β and TNF-α production. TNF-α plays a
role in defense against MCMV infection by activation of
antiviral activities of T and NK cells (Orange and Biron,
1996), but is also critical in MCMV-induced liver damage
in normal or immunodeficient hosts (Orange et al., 1997).
TNF-α-mediated signaling is required for the development of
early necrotic foci in the livers of MCMV-infected C57BL/6J
Rag-/- mice and the NK- and T- cell-deficient E26 mice,
indicating that the main source of TNF-α are non-immune
liver cells.
Galectins play an important role in the regulation of major
cellular functions such as cell attachment, spreading, migration,
proliferation (Elola et al., 2007). Gal-3 also regulates cell signaling
and apoptosis (Markowska et al., 2011), and plays different
roles in the pathogenesis of many inflammatory, infectious
and malignant diseases (Radosavljevic et al., 2011; Volarevic
et al., 2012; Arsenijevic et al., 2016; Simovic Markovic et al.,
2016). An increased expression of Gal-3 was observed in human
T lymphotropic virus-1 infection (Hsu et al., 1996), as well
as in Junin virus-induced central nervous system lesions, but
its role in the pathogenesis of viral disease is not revealed
(Jaquenod De Giusti et al., 2011).
We have previously shown that deletion of galectin-3 gene,
Lgals3, prevents ConA-induced hepatitis and that Gal-3 regulates
the capacity of dendritic cells to promote NKT cell induced liver
injury (Volarevic et al., 2012, 2015). Further, Lgals3 ablation
enhances liver steatosis, but attenuates inflammation and IL-
33 dependant fibrosis in mouse model of non-alcoholic fatty
liver disease (NAFLD) (Jeftic et al., 2015), and enhances bile
duct damage and liver fibrosis in xenobiotic induced primary
biliary cholangitis (PBC) (Arsenijevic et al., 2016). Also Gal-3
overexpression was found in hepatocellular carcinoma (Hsu et al.,
1999). The role of Gal-3 in viral hepatitis is not understood.
In order to explore possible role of Gal-3 in the development
of MCMV-induced hepatitis we used Gal-3 deficient mice
on C57BL/6 background and two strains of MCMV. Our
results provide the first evidence that Lgals3 deletion promotes
MCMV-induced liver inflammation and enhances MCMV-
induced hepatitis by facilitation of TNF-α-dependent hepatocyte
death. This effect appears to be independent of NK cells.
Moreover, TNF-α blockade before MCMV infection attenuates
apoptosis of hepatocytes. Treatment of MCMV-infected Gal-3
KO mice with recombinant Gal-3 reduces liver necrosis and
inflammation. Thus, our data show that Gal-3 plays an important
role in MCMV-induced liver damage and therefore may be
a potential target for therapeutic intervention in acute CMV-
induced liver disease.
MATERIALS AND METHODS
Mice
Gal-3–deficient mice on the C57BL/6 background (Gal-3 KO)
and wild-type (WT) C57BL/6 mice (6–8 weeks of age) were
used in the experiments. Breeding pairs of WT and Gal-3
KO mice were obtained from the University of California,
Davis, United States (Davis, CA, United States; by courtesy of
D.K. Hsu and F.T. Liu). All animal procedures were approved
by the Ethics Committee of Faculty of Medical Sciences,
University of Kragujevac and conducted in accordance with the
National Institutes of Health guidelines for humane treatment
of laboratory animals. Unless otherwise stated each experimental
group in each experiment contained six animals.
Viruses
The bacterial artificial chromosome (BAC)-derived MCMV
strain MW97.01 has previously been shown to be biologically
equivalent to MCMV strain Smith (VR-1399) and is hereafter
referred as WT MCMV (Wagner et al., 1999). Mice were injected
intraperitoneally (i.p.) with 1 × 105 PFU of MCMV strain
MW97.01 in a volume of 200 µL of diluent (PBS). Mice were
also infected with MW97.01, the mutant virus lacking m157 gene
(1m157 MCMV) intravenously (i.v.) with 2 × 105 PFU in a
volume of 100 µL of diluent (PBS).
Serum Levels of Transaminases
Serum levels of asparate aminotransferase (AST) and alanine
aminotransaminase (ALT) were measured 36 and 72 h after
MCMV infection by standard photometric method using the
automated biochemistry analyzer Olympus AU 400 (Olympus
Diagnostica GMBH, Hamburg, Germany) and Olympus
AU reagents, according to the manufacturer’s instructions,
expressed in U/L.
Histological Analyses
The isolated livers were fixed in 10% phosphate-buffered
formalin, embedded in paraffin, and consecutive 4 µm tissue
sections were cut at various depths and mounted on slides.
Sections were stained with Hematoxylin and Eosin (H&E) and
every fourth (six slides) was evaluated for inflammation and
necrosis in the liver. Section examined under low-power light
microscopy (BX51; Olympus) equipped with digital camera.
Scores of cumulative liver pathology for inflammation and
necrosis were presented using the following scoring system:
0, normal (no pathology); 1, mild (1–3 abnormal areas); 2,
moderate (3–5 abnormal areas); 3, severe (>5 abnormal areas).
To determine the number of inflammatory infiltrates, whole liver
tissue was sectioned at three non-subsequent depths and ten
different fields were counted/section. Histological samples were
blinded prior to evaluation.
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Immunohistochemical Detection of
Galectin-3 and TNF-α
Formalin-fixed, paraffin-embedded mouse liver tissue sections
were incubated with rabbit anti-TNF-α (ab66579, Abcam), rabbit
anti-caspase-3, active/cleaved (NB100-56113, Novus Biologicals),
anti-caspase 3 and rabbit anti-Gal-3 (ab53082, Abcam). Sections
were visualized by rabbit-specific conjugate (Expose Mouse
and RabbitSpecific HRP/DAB Detection IHC Kit; Abcam)
and photomicrographed with a digital camera mounted on
light microscope (BX51; Olympus). Virus-infected cells were
visualized by anti-IE1 staining (MCMV protein expressed with
early kinetics).
Detection of Cell Death by TUNEL
Staining
TUNEL (terminal deoxynucleotidyl transferase mediated
dUTP nickend labeling) staining was performed to assess
death hepatocytes in livers sections. Formalin-fixed, paraffin-
embedded tissue sections were stained with in situ Cell Death
Detection Kit, POD (Roche) following the instructions of
manufacturer. DAB (3,3′-diaminobenzidine) as peroxidase
substrate, was used to yield the characteristic brown color for
nuclei. Slides were counterstained with hematoxylin solution
and photomicrographed with a digital camera mounted
on light microscope. The TUNEL-positive nuclei (brown)
were quantified under ×400 magnification in five randomly
fields and the data were summarized as the mean number of
positive cells.
Isolation of Hepatic Mononuclear Cells
and Flow Cytometry
The isolation of liver-infiltrating inflammatory mononuclear
cells was conducted as previously described (Volarevic et al.,
2012). The isolated liver-infiltrating mononuclear cells were
stained with fluorochrome-conjugated antibodies, including
CD3, CD49b, CD8, NKG2D, CD69, perforin, granzyme B,
NF-κB, IFN-γ, IL-10, IL-17, and TNF-α. Isotype Abs with
matching conjugates were used as negative controls. For
intracellular staining, cells were activated with PMA/ionomycin
and processed as previously described (Milovanovic et al., 2012).
Cells were analyzed with the FACSCalibur Flow Cytometer
(BD Biosciences), and analysis was conducted with FlowJo
(Tree Star).
Infliximab Treatment
In order to inhibit production of TNF-α, mice were injected with
chimeric monoclonal antibody, Infliximab (Remicade, JANSSEN
BIOLOGICS B.V.), 5 mg/kg in 200 µL of saline intraperitoneally
1 h before MCMV infection. Mice were sacrificed 48 h
after infection.
Treatment With Recombinant Galectin-3
WT and galectin-3 KO mice were treated with
recombinant Galectin-3, 5 µg per mouse (Peprotech,
Rocky Hill, NJ, United States) intraperitoneally, 2 h
before MCMV infection. Mice were sacrificed 36 h after
MCMV infection.
Isolation of Hepatocytes and Flow
Cytometry
Hepatocytes were isolated as previously described (Li et al., 2010).
Briefly, extirpated livers were transferred HBSS, cutinto 1 mm3
size pieces and washed in complete DMEM. Dissected tissue
was centrifuged at 800 × G for 4 min, pellet resuspended in
digestion medium (0.6% NaCl, 0.05% KCl, 1.2% HEPES, 0.07%
CaCl2, 3 g/mL collagenase type I) and incubated for 20 min
at 37◦C. After incubation cells centrifuged at 800 × G for
4 min, pellet was washed twice in a complete DMEM, passed
through the 100 µm filter and cells centrifuged at 600 × G
for 4 min. Pellet that contains hepatocytes was resuspended in
DMEM medium with FBS. Isolated hepatocytes were washed in
cold PBS and resuspended in 1X binding buffer (10X binding
buffer: 0.1 M Hepes/NaOH (pH 7.4), 1.4 M NaCl, 25 mM CaCl2)
at concentration 1 × 106/mL. Annexin FITC and propidium
iodide (PI) were added to the 100 µL of cell suspension and
incubated for 15 min at room temperature (25◦C) in the dark.
After incubation 400 µL of 1X binding buffer was added to each
tube and stained cells were analyzed within 1h using FACSCalibur
(BD, San Jose, United States) and FlowJo software (Tri Star).
For detection of cell surface expression of calreticulin, isolated
hepatocytes were stained with anti-calreticulin antibody (Abcam)
and analyzed by FACSCalibur (BD, San Jose, United States) and
FlowJo software (Tri Star).
Measurement of TNF-α and HMGB1
Levels of TNF-α and HMGB1 in the liver homogenate were
measured using ELISA kits (R&D Systems, Minneapolis, MN,
United States for TNF-α and Elabscience for HMGB1) according
to the manufacturer’s instructions.
Statistical Analysis
All statistics were carried out using SPSS 18.0 for Windows
software. Results were analyzed using the Student’s t-test or
Mann–Whitney test and ANOVA or Kruskal–Wallis. Data in
this study were expressed as the mean + SE or +SD. Values of
P < 0.05 were considered significant.
RESULTS
MCMV Infection Increases the
Expression of Galectin-3 in Hepatocytes
Previously, we have shown very weak expression of Gal-3 in the
liver parenchyma and biliary epithelial cells in healthy C57BL/6
mice (Arsenijevic et al., 2016). Also we found strongly enhanced
expression of Gal-3 in patients with virus induced hepatitis
(Volarevic et al., 2015). To explore the effect of MCMV infection
on Gal-3 expression in mouse livers, immunostaining of Gal-
3 in the livers of WT and Gal-3 KO mice was done 36 and
72 h after MCMV infection. Time-dependent increase of Gal-
3 expression in hepatocytes after MCMV infection was noticed
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FIGURE 1 | Acute MCMV infection increases Gal-3 expression in hepatocytes. (A) Representative sections of Gal-3 expression in the liver of WT and KO mice 36
and 72 h after MCMV infection with 1 × 105 PFU/animal and the control uninfected liver from WT and KO mice. (B) Liver tissue was sectioned at three
non-subsequent depths. Gal-3 positive hepatocytes were counted in ten different fields and presented as mean number + SD of positive cells per section, six mice
per group, ∗∗∗p < 0.001.
in the livers of WT mice (Figure 1A). Significantly higher
number of Gal-3 expressing hepatocytes per field was noticed
72 h after infection when compared with liver sections obtained
36 h after MCMV infection (Figure 1B). As a control, Gal-
3 was not detected in the livers of untreated and KO infected
mice (Figure 1A).
The Abscence of Gal-3 Enhances Virus
Induced Hepatitis and MCMV Titers in
the Liver
In light of increased Gal-3 expression in hepatocytes of MCVM-
infected mice, we wanted to explore the role of Gal-3 in overall
severity of MCMV-induced hepatitis. For this, histological and
serological parameters of liver damage were analyzed in WT
and Gal-3 KO mice, 36 and 72 h after MCMV infection.
Histological parameters related to MCMV-induced hepatitis,
liver inflammation and necrosis were more pronounced in
Gal-3 KO mice, 36 and 72 h after infection (Figures 2A,B).
No difference in the architecture of liver tissue was noticed
between WT and Gal-3 KO uninfected mice (Figure 2A). Bigger
necrotic areas and inflammatory foci were observed in the livers
of Gal-3 KO mice in comparison with WT mice, 36 h after
infection (Figures 2A,B). Similar differences between Gal-3 KO
and WT mice in the size of necrotic areas were observed 72 h
after infection also (Figures 2A,B). At this time point, there
was no difference in the size of inflammatory foci between
the two groups (Figure 2A), but Gal-3 KO mice had higher
number of smaller inflammatory foci compared with WT mice
(Figure 2A). Although HCMV infection in immunocompetent
hosts is subclinical, it is often accompanied with elevated serum
levels of transaminases. Thus, we examined the level of alanine
transaminase (ALT) in the sera of infected mice. In line with
histological findings, we observed significantly higher level of
ALT in the sera of Gal-3 KO mice 36 h after MCMV infection,
compared to WT mice (Figure 2C).
In order to further analyze the liver damage in WT and KO
mice after MCMV infection we used TUNEL assay. As shown
in Figures 2D,E, 72 h after MCMV infection, the livers of Gal-
3 KO mice contains significantly higher number of TUNEL
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FIGURE 2 | Galectin-3 deficiency enhances MCMV-induced hepatitis. WT and Gal-3 KO mice were i.p. infected with 1 × 105 PFU/animal. Livers were analyzed 36
and 72 h after virus infection. (A) H&E staining of paraffin embedded liver sections. Black arrows highlight necrotic areas, and white arrows indicate inflammatory
foci. (B) Scores of cumulative liver pathology for apoptosis/necroptosis and inflammation; the height of each bar represents the mean of the total histological score (6
animals per group). (C) ALT levels were determined in the serum 36 and 72 h after virus infection. (D) TUNEL staining of liver sections 72 h after MCMV infection.
(E) Quantitative analysis of cell death rate: TUNEL-positive nuclei (brown) were counted in five random fields, and the data were summarized as the mean number of
positive cells. (F) Apoptotic cells were visualized by anti-caspase-3 staining (shown in red). Two representative images are shown/group. (G) Apoptosis of
hepatocytes isolated from MCMV infected WT and KO mice was analyzed by flow cytometry using Annexin V (FITC) and PI double staining. (H) Concentration of
HMGB1 in the liver tissue homogenate 36 h p.i. determinated by ELISA. (I) Percentage of hepatocytes expressing membrane surface calreticulin isolated from the
livers 36 h p.i. determined by flow cytometry. (J) Viral titres in liver is determined by standard plaque assay at 3 days p.i. (K) Virus-infected cells are revealed by
anti-IE1 staining (shown in brown). Two representative images are shown/group. The data are presented as means +SE, or means+SD, 7 mice per group,
∗∗∗p < 0.001; ∗p < 0.05; two tailed, unpaired Student’s t-test.
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FIGURE 3 | Liver inflammatory NK cells are attenuated in Gal-3 KO mice. Flow cytometry of mononuclear cells isolated from livers of WT and KO 36 and 72 h after
i.p. infection with 1 × 105 PFU/animal MCMV was done. Percentages (A) and absolute numbers (B) of NK cells calculated per liver. (C) Total numbers of IFN-γ+,
IL-17+, and IL-10+ NK cells 36 and 72 h after infection calculated per liver. (D) Images of H&E stained liver sections obtained from C57BL/6 and KO mice 72 h after
intravenous infection with MCMV1m157 (2 × 105 PFU/animal). (E) Number of inflammatory cell infiltrates (indicated by black arrows in D) determined by manual
counting. Data are presented as the mean + SE, 15 mice per group, ∗∗∗p < 0.001; ∗∗p < 0.005; ∗p < 0.05; two tailed, unpaired Student’s t-test.
positive (brown nuclei) hepatocytes than the livers of WT mice.
Moreover, higher number of apoptotic (caspase 3 positive)
cells per one inflammatory infiltrate was detected in Gal-3 KO
compared to the WT livers (Figure 2F, red dots). To confirm
the increased apoptosis of hepatocytes in Gal-3 KO mice, we
isolated hepatocytes from WT and Gal-3 KO mice 72 h after
MCMV infection and measured the percentage of apoptotic cells
by flow cytometry. In line with histological observations, we
detected significantly higher percentage of apoptotic (Annexin
V positive) hepatocytes isolated from infected Gal-3 KO mice,
compared with those from WT mice (Figure 2G). Given the
marked necrotic fields in the liver sections from Gal-3 KO mice
(Figures 2A,B) and the ability of MCMV to induce necroptosis
(Upton et al., 2017), we examined markers of necroptotic death,
HMGB1 in liver tissue homogenates and membrane expression
of calreticulin on hepatocytes, 36 h after infection. We have
found significantly higher concentration of HMGB1 in the liver
homogenates (Figure 2H) and higher percentage of hepatocytes
expressing calreticulin on membrane surface (Figure 2I) in Gal-3
KO mice in comparison with infected WT mice.
In the livers of Gal-3 KO mice, there is a significant
increase in viral titers compared to the livers of wild-type mice
(Figure 2J). There was no significant difference in viral titers in
lung and spleen between WT and Gal-3 KO mice, 72 h after
infection (Supplementary Figure S1A). At 8 days post-infection
(Supplementary Figure S1B), viral plaques in spleen were not
detected with the exception of a very low titer in one Gal-3 KO
animal. In lungs, liver and salivary gland, viral plaques were
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FIGURE 4 | Galectin-3 deficiency enhances the expression of TNF-α in hepatocytes of infected animals. (A) Sections of TNF-α liver immunohistochemistry 36 and
72 h after MCMV infection. (B) Quantitative analysis of TNF-α positive hepatocytes: positive hepatocytes were counted in five random fields, and the data were
summarized as the mean number of positive cells. (C) Concentration of TNF-α in the liver tissue homogenate determinated 72 h p.i. by ELISA. Percentage of
TNF-α+ (D) and NF-κB+ (E) hepatocytes and (F) total number of CD11c+ TNF-α+ cells determined by flow cytometry 72 h after infection. Data are presented as the
mean + SE, six mice per group, ∗p < 0.05, ∗∗∗p < 0.001, two tailed, unpaired Student’s t-test.
readily detected but no significant differences were observed
between the two groups. Lastly, to demonstrate the presence
of virus-infected cells, sections of liver were stained with an
antibody against IE1, a MCMV protein expressed with early
kinetics. As shown in Figure 2K, in the liver tissue of Gal-3 KO
mice, higher number of infected cells was observed compared to
the WT animals.
Together, previous data indicate protective role of Gal-3
in MCMV-induced hepatitis, possibly relating to its increased
expression in hepatocytes and known role of Gal-3 in attenuation
of cell death (Takenaka et al., 2004).
Enhanced Disease in Gal-3 KO Mice Is
Independent of NK Cell Activation
Taking into account the facts that NK cells play a crucial role
in the early immune response against MCMV in C57BL/6 mice
(Scalzo and Yokoyama, 2008) and that NK cells contribute
to liver damage in viral infections (Zheng et al., 2015), we
explored the possibility that bigger liver damage in infected Gal-
3 KO mice is a consequence of stronger NK cell activity. We
analyzed the presence and the phenotype of NK cells in liver
mononuclear infiltrates in WT and Gal-3 KO mice, 36 and
72 h after MCMV infection. There was no statistically significant
increase in the percentage and total number of NK cells in the
livers of infected Gal-3 KO mice in comparison with uninfected
Gal-3 KO mice (Figures 3A,B). On the other hand, MCMV
infection induced a significant increase in both total number and
percentage of NK cells in the livers of WT mice (Figures 3A,B).
Total number of IFN-γ expressing NK cells 36 h after MCMV
infection was significantly higher in the livers of WT mice in
comparison with Gal-3KO mice, while 72 h after infection this
difference lost significance (Figure 3C). No significant difference
in the percentage and total number of NK cells expressing IL-
17 was noticed between the groups. Lastly, total number of
IL-10 positive NK cells was significantly higher in the liver
of Gal-3 KO mice in comparison with WT mice, 36 h after
infection (Figure 3C).
In order to exclude the role of NK cells in the higher liver
damage in Gal-3 KO mice, we analyzed liver damage in WT
and KO mice after infection with 1m157 MCMV, the mutant
virus lacking m157 gene, which does not stimulate NK cells. As
observed for WT MCMV, the inflammatory cell infiltrates were
readily observed in the liver tissue of both wild-type and Gal-3
KO infected mice (Figure 3D, black arrows). No difference in
the size of infiltrates was observed between the two groups but,
interestingly, the number of infiltrates was significantly higher
in Gal-3 KO mice compared to the wild-type mice (Figure 3E).
Thus, enhanced liver damage in MCMV-infected Gal-3 KO mice
does not appear to relate to NK cell activity.
The Expression of TNF-α in Hepatocytes
Is Increased in MCMV-Infected Gal-3 KO
Mice
Based on our finding of enhanced necoptosis in Gal-3 KO
mice and the fact that TNF-α signaling triggers necroptosis
(Vandenabeele et al., 2010) and is required for MCMV-induced
liver damage (Orange et al., 1997), TNF-α detection in the livers
of MCMV-infected mice was done. The expression of TNF-
α in hepatocytes was detected by immunostaing the livers of
MCMV-infected mice both, WT and Gal-3 KO (Figure 4A).
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FIGURE 5 | TNF-α blockade attenuates liver inflammation and necrosis in MCMV-infected Gal-3 KO mice. WT and KO mice were i.p. infected with 1 × 105
PFU/animal. Chimeric monoclonal antibody, Infliximab (5 mg/kg) was administrated intraperitoneally 1 h before MCMV infection. Mice were analyzed 48 h p.i.
(A) H&E staining of paraffin embedded liver sections. Black arrows highlight necrotic areas, and white arrows indicate inflammatory foci. (B) Number of inflammatory
cell infiltrates per section (indicated by white arrows in A) was determined by manual counting. (C) Number of necrotic foci per section (indicated by black arrows in
A) was determined by manual counting. (D) ALT levels determined in the serum. Data are presented as mean + SE of n = 6 mice. ∗∗∗p < 0.001; ∗p < 0.05 from two
tailed, unpaired Student’s t-test.
The number of TNF-α positive hepatocytes was significantly
higher in the livers of Gal-3 KO mice compared to the group of
infected WT mice, 36 and 72 h after infection (Figure 4B). Also,
the concentration of TNF-α in the liver tissue homogenate was
significantly higher in the group of Gal-3 KO mice compared to
the group of WT mice, 72 h after MCMV infection (Figure 4C).
Further, significantly higher percentage of TNF-α+ hepatocytes
(Figure 4D), and total number of TNF-α+ CD11c+ cells
(Figure 4E), analyzed by flow cytometry 72 h after MCMV
infection, were found in the group of Gal-3 KO mice in
comparison with WT mice. In accordance with the role of
NF-κB in the promotion of TNF-α expression and its role in
TNF-α mediated actions, significantly higher percentage of NF-
κB+ hepatocytes was found in the group of Gal-3 KO mice in
comparison to WT mice, 72 h after infection (Figure 4F). These
results suggest that higher TNF-α expression in hepatocytes and
immune cells could be the cause of enhanced MCMV-induced
hepatocyte death observed in Gal-3 KO mice.
Inhibition of TNF-α Binding Alleviates
MCMV-Induced Hepatitis
In order to further explore the possibility that TNF-α plays
a role in enhanced MCMV-induced liver damage in Gal-3
deficient animals, pharmacological inhibition of TNF-α with
infliximab was done before infection. In the control group of
WT mice, TNF-α blockade before MCMV infection did not
alter liver inflammation or necrosis, while a pre-treatment of
MCMV-infected Gal-3 KO mice with infliximab significantly
decreased liver inflammation and necrosis (Figures 5A–C). Liver
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FIGURE 6 | Gal-3 is protective in MCMV-induced hepatocyte damage. (A) H&E staining of paraffin embedded liver sections in WT and KO mice treated with
recombinant Galectin-3 (50 µg/mL) intraperitoneally 2 h before MCMV infection, analyzed 72 h after infection. (B) Scores of cumulative liver pathology for
apoptosis/necroptosis and inflammation. (C,D) Number of inflammatory cell infiltrates and necrotic areas per section determined by manual counting. Data are
presented as mean + SE of n = 8 mice. ∗∗∗p < 0.001; ∗p < 0.05 from two tailed, unpaired Student’s t-test.
of untreated MCMV-infected Gal-3 KO mice contained bigger
inflammatory and necrotic foci in comparison to the liver
of infliximab-pretreated mice (Figure 5A). Also, the TNF-α
blockade before MCMV infection significantly decreased serum
levels of ALT in Gal-3 KO mice (Figure 5D). Ameliorated
MCMV-induced hepatitis in Gal-3 KO mice treated with
infliximab supports the role of TNF-α in enhanced disease in
Gal-3 deficient animals.
Exogenous Gal-3 Alleviates
MCMV-Induced Liver Damage
To confirm the protective role of Gal-3 in MCMV-induced
hepatitis disease severity in WT and Gal-3 KO mice treated
with recombinant Gal-3 was evaluated. Administration of
recombinant Galectin-3 did not significantly alter inflammation
and necrosis in WT mice (Figures 6A,B). Although we have
not observed an altered number of inflammatory foci per liver
in WT mice, there was an increase in their size (Figure 6A,
white arrows). Gal-3 KO mice treated with recombinant
Galectin-3 had lower histological score of necrosis and
inflammation and lower number of inflammatory and necrotic
foci per section, 72 h after MCMV infection (Figures 6A–D).
Alleviated disease in Gal-3 KO mice treated with recombinant
Galectin-3 confirms the protective role of Gal-3 in MCMV
induced hepatitis.
DISCUSSION
Here, we provide the first evidence that Gal-3 plays a protective
role in MCMV-induced hepatitis as indicated by higher liver
damage, serum levels of ALT and higher virus titers in Gal-
3 deficient mice (Figure 2). Further exogenous Gal-3 alleviates
MCMV-induced liver damage (Figure 6).
Several clinical studies indicate an increased serum level
of Gal-3 in viral infections (Ten Oever et al., 2013; Lukic
et al., 2017), and point out Gal-3 as a potential marker of
viral infection (Kobayashi et al., 2015). Findings obtained in
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FIGURE 7 | Role of Gal-3 in MCMV-induced hepatitis. In the presence of Gal-3 (left panel) liver infiltrating NK cells contain IFN-γ and take a role in viral clearance.
MCMV in hepatocytes induce apoptosis and necroptosis, membrane expression of calreticulin (CALR), release of pro-inflammatory molecule HMGB-1, and TNF-α
production. TNF-α binds TNFR and additionally stimulates apoptosis, but intracellular Gal-3 protects hepatocytes from cell death. Result is controlled liver damage
and lower viral titers. In Gal-3 KO mice (right panel) NK cells that contain more IL-10 are poorer in controlling the virus, leading to increased virus-induced apoptosis
and necroptosis. Increased death of Gal-3 KO hepatocytes is accompanied with higher expression of CALR and HMGB1 release that stimulates TNF-α in CD11c+
cells. More MCMV in Gal-3 KO hepatocytes induce higher NF-κB mediated production of TNF-α that augments apoptosis of hepatocytes, and in the absence of
protective effect of Gal-3 results in more severe liver damage in Gal-3 KO mice.
animal model of coxsackievirus B3 virus induced cardiac injury
in C57BL/6 mice studies indicate a protective role of Gal-
3 in viral-induced diseases (Jaquenod De Giusti et al., 2015).
Here, we show that Gal-3 gene deletion leads to accelerated
liver damage induced by MCMV infection. In C57BL/6 mice,
Gal-3 deletion enhances liver disease which is characterized by
higher liver infiltrates and necrosis (Figures 2A,B), increased
serum level of ALT (Figure 2C), enhanced apoptosis and
necroptosis of hepatocytes (Figures 2D–I), higher viral titers
(Figure 2J) and higher number of MCMV-infected cells
in liver (Figure 2K). Further, a pretreatment of MCMV-
infected Gal-3 KO mice with recombinant Gal-3 reduced the
inflammation and liver damage in MCMV-induced hepatitis
(Figure 6). The diverse effects of Gal-3 in different inflammatory
conditions depend on the dominant pathogenic mechanisms
involved. In macrophage mediated carditis and cardiac fibrosis
induced by coxsackievirus B3 virus disruption of Gal-3 gene,
or pharmacological inhibition of Gal-3, has the protective
role (Jaquenod De Giusti et al., 2015). We also previously
reported that Gal-3 gene deletion alleviates T and NKT
cell mediated hepatitis (Volarevic et al., 2012, 2015). But,
in line with finding of this study is our previous report
that Gal-3 gene deletion aggravates xenobiotic induced PBC
(Arsenijevic et al., 2016) due to enhanced hepatocyte apoptosis
and release of autoantigens.
NK cells play a crucial role in the early immune response
against murine cytomegalovirus infection and in the clearance
of MCMV in C57BL/6 mice (Scalzo and Yokoyama, 2008).
NK cells, also contribute to liver damage in viral infections
(Zheng et al., 2015). Although NK cells express Gal-3 that
mainly downregulates their inflammatory and cytotoxic activities
(Radosavljevic et al., 2011), higher liver damage in Gal-3 KO
mice was not accompanied with higher activity of NK cells
(Figure 3). Here, we have demonstrated that WT mice had
higher influx of NK cells in the liver in comparison with Gal-
3 KO mice (Figures 3A,B). Higher total number of IFN-γ
expressing and lower total number of IL-10 expressing NK
cells was noticed in the livers of WT mice (Figure 3C). In
accordance with previous report that NK cells as the main
source of IFN-γ, which plays a pivotal role in the antiviral
response (Jost and Altfeld, 2013), our results indicate that
lower viral titers in the livers of WT mice (Figure 2J) are
the result of enhanced activity of NK cells in these mice in
comparison with Gal-3 KO mice. The absence of NK cells
involvement in higher liver damage in Gal-3 KO mice was
confirmed by experiments with MCMV1m157 infection. The
stimulation of activating Ly49H receptor of NK cells with
MCMV-encoded protein m157, has a crucial role in early
MCMV control and resistance to MCMV infection (Smith
et al., 2002). The deletion of m157 gene or blocking the
Ly49H receptor on NK cells abrogates the control of MCMV
infection in most of the organs (Brown et al., 2001; Lee
et al., 2001; Bubic et al., 2004; Sumaria et al., 2009). Higher
number of liver infiltratesin Gal-3 KO mice infected with
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MCMV1m157 in comparison with MCMV1m157 infected WT
mice (Figures 3D,E) suggests that higher activity of NK cells
doesn’t play important role in enhanced liver damage of Gal-
3 KO mice.
Acute MCMV infection generates an early systemic
inflammatory response characterized by high levels of TNF-
α, IL-12, IFN-γ, and type I IFNs (Orange and Biron, 1996;
Nguyen et al., 2002). TNF-α mediates MCMV-induced liver
damage independently of T and NK cells. It is required for
the development of early hepatic necrotic foci and increased
levels of liver enzymes (Orange et al., 1997). Our results
indicate that hepatocytes are a significant source of TNF-α in
MCMV infection (Figure 4). Although TNF-α is traditionally
described as cytokine secreted by the cells of innate immunity
(Wajant et al., 2003), tissue-specific cells also produce TNF-α
(Gonzalez-Amaro et al., 1994; Bluml et al., 2012; Yoshigai
et al., 2014). Production of TNF-α in the livers of MCMV
infected mice depends on TLR3, TLR7, and TLR9 signaling
(Zucchini et al., 2008; Crane et al., 2012) and also on activity of
MAPK-activated protein kinase 2 (Ehlting et al., 2016). Since,
we found MCMV-infected hepatocytes (Figure 2K) it can be
assumed that MCMV directly stimulates TNF-α production
in hepatocytes. We detected higher expression of TNF-α and
higher number of TNF-α expressing hepatocytes in the liver
of MCMV-infected KO mice (Figure 4). Additionally, TNF-α
blockade with monoclonal antibody, Infliximab, significantly
reduced hepatocyte death in MCMV-infected mice, especially
in Gal-3 KO mice (Figure 5). TNF-α sensitizes hepatocytes to
both caspase-dependant and caspase-independent apoptosis
(Jones et al., 2000), and triggers necroptosis (Vandenabeele
et al., 2010). Taking into account these observations, it
appears that the higher production of TNF-α in hepatocytes
of MCMV-infected Gal-3 KO mice contributes to greater
liver damage.
Normal hepatocytes do not express Gal-3 in humans
(Arsenijevic et al., 2016), but expression of Gal-3 is increased
in different liver diseases (Shimonishi et al., 2001). Here, we
have shown no Gal-3 expression in hepatocytes of untreated
mice and a time-dependant increase of Gal-3 expression in
hepatocytes of MCMV-infected WT mice (Figures 1A,B).
This finding is in accordance with previously reported up-
regulated expression of Gal-3 in mouse CNS tissue after
encephalomyocarditis virus infection (Kobayashi et al., 2015)
and in microglia and astrocytes of mice infected with Junin
virus (Jaquenod De Giusti et al., 2011). Recently, it has been
shown that TNF-α increases expression of Gal-3 (Okamoto
et al., 2019), indicating that MCMV-induced Gal-3 expression
in hepatocytes could be the result of virus-induced TNF-α
production. The deletion of galectin-3-encoding gene sensitizes
human keratinocytes, colorectal cancer cells, leukemia cells,
human renal cell carcinoma and cholangyocarcinoma cells to
apoptosis (Shi et al., 2007; Wongkham et al., 2009; Cheng
et al., 2011; Xu et al., 2013), whereas the overexpression of
Lgals3 protects the cells from apotosis (Takenaka et al., 2004).
Gal-3 inhibits TNF-related apoptosis-inducing ligand, TRAIL,
induced apoptosis by activation of the PI3K/Akt pathway which
blocks loss of the mitochondrial membrane potential, resulting
in inhibition of caspase-9 and caspase-3 activation (Oka et al.,
2005). In accordance with this, we found higher percentage
of TNF-α positive (Figures 4A–D) and apoptotic hepatocytes
(Figures 2D–G) in infected Gal-3 KO mice, compared to WT
mice. Further, we found significantly higher HMGB1 release
(Figure 2H) and percentage of calreticulin positive hepatocytes
(Figure 2I), markers of necroptotic death (Kepp et al., 2014), in
the livers of infected Gal-3 KO mice compared with WT mice.
HMGB1 binds to several receptors on the surface of immune cells
(TLR2, TLR4, RAGE) and mediates strong inflammation (Scaffidi
et al., 2002), while exposed calreticulin binds to receptors on
antigen presenting cells and stimulates phagocytosis (Chao et al.,
2010). It can be assumed that higher necroptosis of hepatocyte in
Gal-3 deficient mice, early after MCMV infection, accompanied
with higher release of HMGB1 (Figure 2J), enhances liver
inflammation and TNF-α production in innate immune cells
(Figure 4F) which in turn activates NF-kB in hepatocytes and
subsequently augments the expression of innate cytokines (TNF-
α) in hepatocytes (Zhou et al., 2016) leading to enhanced liver
damage.
Finally, our data suggest that the increased expression of
Gal-3 in MCMV-infected livers protects hepatocytes from TNF-
α facilitated apoptosis and necroptosis, and consequentially
attenuates liver damage in MCMV-induced hepatitis (Figure 7).
This findings combined with reduced MCMV-induced liver
damage after recombinant Gal-3 treatment indicate protective
role for Gal-3 in MCMV-induced liver damage, which can be of
therapeutic relevance.
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